Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy

Author(s):
Hanoteau, A.; Newton, J.M.; Krupar, R.; Huang, C.; Liu, H.C.; Gaspero, A.; Gartrell, R.D.; Saenger, Y.M.; Hart, T.D.; Santegoets, S.J.; Laoui, D.; Spanos, C.; Parikh, F.; Jayaraman, P.; Zhang, B.; Burg, S.H. van der (0000-0002-6556-0354); Ginderachter, J.A. van; Melief, C.J.M.; Sikora, A.G.
Published
2019
Publication type
Article / Letter to editor
ImmunotherapyTumor microenvironmentInducible nitric oxide synthase (iNOS)CyclophosphamideL-n6-(1-iminoethyl)-lysine (L-NIL)ChemoradiotherapyRadiotherapyHead and neck squamous cell carcinomaHead and neck cancerHuman papillomavirus (HPV)
Date issued
2019-01-15
Language
English
Is part of
Journal for ImmunoTherapy of Cancer
hdl
1887/119522
doi
10.1186/s40425-018-0485-9